Type 2 Diabetes

Higher Complications, Comorbidities in Youth With Type 2 Versus Type 1 Diabetes

Higher Complications, Comorbidities in Youth With Type 2 Versus Type 1 Diabetes

By

The prevalence of complications associated with type 1 and type 2 diabetes diagnosed during childhood and adolescence was compared in a multicenter, observational study.

Do Higher Temperatures Increase Diabetes Incidence?

Do Higher Temperatures Increase Diabetes Incidence?

Age-adjusted diabetes incidence increased for every 1 degree celcius temperature increase.

Factors Associated With Lack of Diabetes Disease Awareness Identified

Factors Associated With Lack of Diabetes Disease Awareness Identified

A study found approximately one-third of people with diabetes were undiagnosed or unaware of the diagnosis.

Mortality In Type 2 Diabetes Increased With Severe Hypoglycemia Episode

Mortality In Type 2 Diabetes Increased With Severe Hypoglycemia Episode

Researchers identified hypoglycemia as an "under-recognized" risk factor for death and CVD in people with type 2 diabetes.

Brief Intensive Lifestyle and Drug Therapy Beneficial in Type 2 Diabetes

Brief Intensive Lifestyle and Drug Therapy Beneficial in Type 2 Diabetes

Participants who received either an 8- or 16-week course of intensive lifestyle and drug therapy achieved hemoglobin A1c criteria for complete or partial diabetes remission.

Differential Adverse Renal Effects With Dapagliflozin, Empagliflozin in Type 2 Diabetes

Differential Adverse Renal Effects With Dapagliflozin, Empagliflozin in Type 2 Diabetes

By

A comprehensive systematic review analyzes whether specific sodium-glucose cotransporter 2 inhibitors were more likely to be associated with adverse renal events in patients with type 2 diabetes.

Update: ADA Standards of Medical Care in Diabetes Emphasize Metformin Therapy

Update: ADA Standards of Medical Care in Diabetes Emphasize Metformin Therapy

An update to the ADA's 2017 Standards of Medical Care in Diabetes indicates that, barring contraindication, patients with type 2 diabetes should undergo metformin therapy as first-line treatment.

A Clinician's Plea for More Pragmatic Clinical Trials in Diabetes

A Clinician's Plea for More Pragmatic Clinical Trials in Diabetes

By

Studies designed to address real-world challenges can potentially lead to both better-informed clinical decision making and improved outcomes.

Ethnicity-Based Variations in Type 2 Diabetes Risk

Ethnicity-Based Variations in Type 2 Diabetes Risk

Study participants of South Asian ethnicity were more more likely to develop type 2 diabetes with a BMI between 18 and 30 kg/m2.

Insulin Therapy in Pregnant Women With Preexisting Diabetes

Insulin Therapy in Pregnant Women With Preexisting Diabetes

By

Insulin types and regimens should be determined on an individual basis since there is insufficient data to support one treatment over another.

Higher HbA1c Levels May Increase Mortality Risk in Older Patients

Higher HbA1c Levels May Increase Mortality Risk in Older Patients

By

Older patients with diabetes whose hemoglobin A1c levels were greater than 8% had an increased mortality risk.

Positive Outcomes in Type 2 Diabetes Treatment Intensification

Positive Outcomes in Type 2 Diabetes Treatment Intensification

Patients experience greater reductions in HbA1c when intensification of therapy with oral antidiabetic drugs was not delayed.

Metformin, Vidagliptin Associated With Elevated Heart Rate in Type 2 Diabetes

Metformin, Vidagliptin Associated With Elevated Heart Rate in Type 2 Diabetes

While both drugs elevated patient heart rates, only vildagliptin affected blood pressure.

Do Gluten-Free Diets Elevate Type 2 Diabetes Risk?

Do Gluten-Free Diets Elevate Type 2 Diabetes Risk?

Study participants who ate the least amount of gluten (less than 4 grams per day) were the most likely to develop type 2 diabetes.

MACE Risk With Insulin Dosage in Type 2 Diabetes

MACE Risk With Insulin Dosage in Type 2 Diabetes

By

A cohort study of primary care records in the United Kingdom did not find an increased risk of major cardiovascular events in patients with type 2 diabetes treated with insulin.

Liraglutide Reduces Type 2 Diabetes Risk in Prediabetic Patients

Liraglutide Reduces Type 2 Diabetes Risk in Prediabetic Patients

By

A randomized, double-blind, placebo-controlled trial sought to determine whether liraglutide decreased the percentage of patients with prediabetes and obesity who later developed type 2 diabetes.

Exenatide Therapy Associated With Reduced Health Care Costs in Type 2 Diabetes

Exenatide Therapy Associated With Reduced Health Care Costs in Type 2 Diabetes

Once-weekly or twice-daily exenatide has been linked to reduced health care costs associated with type 2 diabetes.

Preoperative Glargine Dosing May Affect Perioperative Glycemic Control

Preoperative Glargine Dosing May Affect Perioperative Glycemic Control

By

Patients who received 60% to 87% of the normal evening glargine dose had the highest likelihood of achieving glycemic control.

Tax on Sugar-Sweetened Beverages Leads to Less Consumption

Tax on Sugar-Sweetened Beverages Leads to Less Consumption

The largest decrease in purchases was noted among households at the lowest socioeconomic level.

FDA Approves Fixed-Dose Dapagliflozin, Saxagliptin for T2D

FDA Approves Fixed-Dose Dapagliflozin, Saxagliptin for T2D

By

Qtern tablets are approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Complication Rates In Adolescents With Type 1 vs Type 2 Diabetes

Complication Rates In Adolescents With Type 1 vs Type 2 Diabetes

Investigators found early signs of kidney disease, retinopathy, arterial stiffness, and hypertension in adolescents with either type 1 or type 2 diabetes.

Using Analogies in Endocrinology to Better Care for Patients

Using Analogies in Endocrinology to Better Care for Patients

By

An endocrinologist discusses the value of using everyday analogies to explain diabetes management issues to his patients.

No Increased Short-Term MI, Stroke Risk With DPP-4i vs SU/TZD

No Increased Short-Term MI, Stroke Risk With DPP-4i vs SU/TZD

There was no short-term risk of myocardial infarction, stroke, or heart failure with dipeptidyl peptidase-4 inhibitors vs sulfonylureas and thiazolidinediones.

Endothelium-Dependent Vasodilation Reduced in T2DM Regardless of Polyneuropathy

Endothelium-Dependent Vasodilation Reduced in T2DM Regardless of Polyneuropathy

Regardless of polyneuropathy, endothelium-dependent vasodilation was reduced in patients with type 2 diabetes.

Should Dentists Screen Periodontitis Patients for Diabetes?

Should Dentists Screen Periodontitis Patients for Diabetes?

Among patients with varying levels of periodontitis, prediabetes or type 2 diabetes diagnoses were common.

BP Effects of Novel Glucagon Receptor Antagonist May Limit Clinical Utility

BP Effects of Novel Glucagon Receptor Antagonist May Limit Clinical Utility

Glucagon receptor antagonist LY2409021 was linked to increases in both systolic and diastolic blood pressure in patients.

Rising Insulin Prices: ADA & Endocrine Society Call for Action

Rising Insulin Prices: ADA & Endocrine Society Call for Action

By

The American Diabetes Association and the Endocrine Society have issued statements with the intent of improving insulin access and affordability.

Adiponectin Independently Associated With Increased Mortality in Diabetics

Adiponectin Independently Associated With Increased Mortality in Diabetics

Further study is required to understand the complex relationship between adiponectin and cardiovascular outcomes in type 2 diabetes with ACS.

GLP-1RA Therapy Plus Exercise for Management of Dysregulated Type 2 Diabetes

GLP-1RA Therapy Plus Exercise for Management of Dysregulated Type 2 Diabetes

GLP-1RA therapy may limit the benefit of exercise on patients with dysregulated type 2 diabetes, according to research.

Benefits of Sustained Weight Loss in Type 2 Diabetes

Benefits of Sustained Weight Loss in Type 2 Diabetes

Over 5 years follow-up, researchers found reduced levels of HbA1c, triglycerides, LDL-cholesterol, and quality of life in patients who reported sustained weight loss.

Sign Up for Free e-Newsletters